Cargando…

Vasoactive Intestinal Polypeptide Promotes Intestinal Barrier Homeostasis and Protection Against Colitis in Mice

Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP’s role in development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiujuan, Conlin, Victoria S., Morampudi, Vijay, Ryz, Natasha R., Nasser, Yasmin, Bhinder, Ganive, Bergstrom, Kirk S., Yu, Hong B., Waterhouse, Chris C. M., Buchan, Allison M. J., Popescu, Oana E., Gibson, William T., Waschek, James A., Vallance, Bruce A., Jacobson, Kevan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416880/ https://www.ncbi.nlm.nih.gov/pubmed/25932952 http://dx.doi.org/10.1371/journal.pone.0125225

Ejemplares similares

Goblet Cell Derived RELM-β Recruits CD4(+) T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation
por: Bergstrom, Kirk S. B., et al.
Publicado: (2015)

Milk Fat Globule Membrane Supplementation in Formula Modulates the Neonatal Gut Microbiome and Normalizes Intestinal Development
por: Bhinder, Ganive, et al.
Publicado: (2017)

Development-Dependent Plasticity in Vasoactive Intestinal Polypeptide Neurons in the Infralimbic Cortex
por: Collins, Stuart A, et al.
Publicado: (2021)

Vasoactive Intestinal Polypeptide (VIP) in the Intestinal Mucosal Nerve Fibers in Dogs with Inflammatory Bowel Disease
por: Rychlik, Andrzej, et al.
Publicado: (2020)

Vasoactive Intestinal Polypeptide-Immunoreactive Interneurons within Circuits of the Mouse Basolateral Amygdala
por: Rhomberg, Thomas, et al.
Publicado: (2018)

Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases
por: Iwasaki, Mari, et al.
Publicado: (2017)

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial
por: Pellesi, Lanfranco, et al.
Publicado: (2021)

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
por: Xu, Yingna, et al.
Publicado: (2022)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
por: Asano, Satoshi, et al.
Publicado: (2022)

Parvalbumin- and vasoactive intestinal polypeptide-expressing neocortical interneurons impose differential inhibition on Martinotti cells
por: Walker, F., et al.
Publicado: (2016)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

Vasoactive Intestinal Polypeptide in the Carotid Body—A History of Forty Years of Research. A Mini Review
por: Gonkowski, Slawomir
Publicado: (2020)

Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females
por: Simon, Rozalyn A., et al.
Publicado: (2021)

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

Bombesin-Like, Substance P and Vasoactive Intestinal Polypeptide Receptors in Fetal Cortical Homografts to Host Cortex and Spinal Cord
por: Moody, Terry W., et al.
Publicado: (1989)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
por: Solés-Tarrés, Irene, et al.
Publicado: (2020)

Pancreatic tumor with hepatic metastases secreting vasoactive intestinal polypeptide: Treatment options and long-term follow-up results
por: Sözen, Mehmet, et al.
Publicado: (2023)

The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota
por: Ericsson, Aaron C., et al.
Publicado: (2022)

Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice
por: Bains, Manpreet, et al.
Publicado: (2019)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

The Impact of T-2 Toxin on Vasoactive Intestinal Polypeptide-Like Immunoreactive (VIP-LI) Nerve Structures in the Wall of the Porcine Stomach and Duodenum
por: Makowska, Krystyna, et al.
Publicado: (2018)

Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes
por: Hogenboom, Rick, et al.
Publicado: (2019)

FRI277 Temporal Coordination Of Female Reproductive Axis Activity By Vasoactive Intestinal Polypeptide (VIP) Expressing Cells In The Suprachiasmatic Nucleus
por: Phumsatitpong, Chayarndorn, et al.
Publicado: (2023)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

A Unique Presentation and Clinical Course of a Pancreatic Vasoactive Intestinal Polypeptide Secreting Tumor in a 68-year-old Male
por: Jagdish, Balaji R., et al.
Publicado: (2020)

A microcircuit model involving parvalbumin, somatostatin, and vasoactive intestinal polypeptide inhibitory interneurons for the modulation of neuronal oscillation during visual processing
por: Wagatsuma, Nobuhiko, et al.
Publicado: (2022)

Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats
por: Xu, Chun-Lan, et al.
Publicado: (2018)

Localization of Vasoactive Intestinal Polypeptide Receptor 1 (VPAC1) in Hypothalamic Neuroendocrine Oxytocin Neurons; A Potential Role in Circadian Prolactin Secretion
por: Stangerup, Ida, et al.
Publicado: (2020)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
por: Ciranna, Lucia, et al.
Publicado: (2021)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Vasoactive Intestinal Peptide–Null Mice Demonstrate Enhanced Sweet Taste Preference, Dysglycemia, and Reduced Taste Bud Leptin Receptor Expression
por: Martin, Bronwen, et al.
Publicado: (2010)

Highly Sensitive, Flow Cytometry-Based Measurement of Intestinal Permeability in Models of Experimental Colitis
por: Tsai, Kevin, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kogkq2ft7nc4dft1o0aj5e6o1m